Lisa D. Nee

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

Rachel Williamson, Jackie F. Price, Stephen Glancy et al. · Diabetes Care · 2011 · 393 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: The Edinburgh type 2 diabetes study

Joanne R Morling, Jonathan Fallowfield, Indra Neil Guha et al. · Journal of Hepatology · 2013 · 71 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes

Insa Feinkohl, M Keller, C. Robertson et al. · Diabetes Care · 2013 · 68 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: Intra- and interobserver variability and comparison with magnetic resonance spectroscopy

Rachel Williamson, Elisa Perry, Stephen Glancy et al. · Clinical Radiology · 2011 · 36 citations

Medicine, Endocrinology, Radiology +17

Non‐invasive hepatic biomarkers (<scp>ELF</scp> and <scp>CK</scp>18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study

Joanne R Morling, Jonathan Fallowfield, Rachel Williamson et al. · Liver International · 2013 · 12 citations · Full text

Medicine, Internal Medicine, Pathology +17